Biomarkers, Diagnostics and Precision Medicine , DABCC,#

Biomarkers, Diagnostics and Precision Medicine in the Drug IndustryCritical Challenges, Limitations and Roadmaps for the Best Practices\nAuthor(s): Abdel Halim\nFormat: Paperback\nPublisher: Elsevier Science Publishing Co Inc, United States\nImprint: Academic Press Inc\nISBN-13: 9780128161210, 978-0128161210\nSynopsis\nThe high failure rate in the pharmaceutical industry has positioned biomarkers and personalized medicine in the frontline, as possible solutions. If executed right, biomarkers and companion diagnostics (CDx) can potentially help the drug industry enhance the probability of success, accelerate the time to market, and, more importantly, benefit patients by supporting accurate diagnosis and selection of the most effective and least toxic therapies. This book aims to examine the challenges and limitations in biomarkers and laboratory tests. It also offers advice on best practices to ensure proper application of biomarkers and bridges the gap between diagnostic business dev.